Hyris provides a decentralized platform for nucleic acid testing, utilizing its proprietary Hyris System™ to enable real-time analysis of biological samples in various settings. This technology enhances diagnostic capabilities beyond traditional laboratories, facilitating access to genetic testing for healthcare, agrifood, and environmental applications.
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AVFounders
Product
Problem
Traditional nucleic acid testing often requires specialized laboratory settings, limiting accessibility and increasing turnaround times for critical diagnostic information. This can delay decision-making in healthcare, agrifood, and environmental monitoring, where rapid results are essential.
Solution
Hyris offers a decentralized platform for real-time analysis of biological samples, enabling genetic testing outside of conventional laboratory environments. The Hyris System™ facilitates on-site nucleic acid testing across various sectors, including healthcare, agrifood, and environmental applications. By providing a portable and user-friendly system, Hyris aims to enhance diagnostic capabilities and broaden access to genetic testing, allowing for quicker and more informed decisions. The Hyris Marketplace™ further expands this ecosystem by connecting kit developers with end-users, creating an open platform for diverse testing needs.
Target Audience
The primary target audience includes healthcare providers, agrifood companies, environmental monitoring agencies, and kit developers seeking to expand access to genetic testing.
Features
- Portable Hyris System™ for on-site nucleic acid analysis
- Real-time results for rapid decision-making
- Decentralized platform enabling testing outside traditional labs
- Hyris Marketplace™ connecting kit developers and end-users
- Applications across healthcare, agrifood, and environmental sectors